Lynkcell Inc.   Report issue

For profit Phase 1
Founded: Sheridan WY United States (2018)

Organization Overview

First Clinical Trial
2018
NCT03644459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Lynkcell Inc.